Skip to main content

Table 3 Risk Factor of the three groups for selected Neonatal Morbidity

From: The glucose infusion rate of parenteral nutrition in the first week of life in preterm infants: an observational study

GIR

n (%)

OR

95% CI

p

Group I

 RDS

10 (47.6)

0.776

0.295–2.043

0.607

 NEC

3 (14.3)

1.944

0.443–8.538

0.372

 Sepsis

1 (4.7)

0.096

0.012–0.757

0.050

 ROP

3 (14.3)

1.643

0.386–6.994

0.498

 Pulmonary hypertension

3 (14.3)

1.944

0.443–8.538

0.372

 Hypoglycemia

9 (42.9)

4.000

1.384–11.565

0.008*

Group II

 RDS

37 (55.2)

1.410

0.594–3.344

0.435

 NEC

4 (5.9)

0.317

0.079–1.280

0.093

 Sepsis

22 (32.8)

2.444

0.824–7.250

0.101

 ROP

7 (10.4)

1.050

0.252–4.373

0.947

 Pulmonary hypertension

5 (7.5)

0.524

0.130–2.109

0.257

 Hypoglycemia

11 (16.4)

0.393

0.145–1.065

0.062

 Hyperglycemia

9 (13.4)

1.009

0.285–3.575

0.989

Group III

 RDS

4 (44.5)

0.698

0.176–2.774

0.608

 NEC

2 (22.2)

3.306

0.574–19.043

0.160

 Sepsis

4 (44.5)

2.261

0.559–9.151

0.243

 ROP

0 (0.0)

1.115

1.039–1.198

0.286

 Pulmonary hypertension

1 (11.1)

1.250

0.138–11.307

0.842

 Hyperglycemia

2 (22.2)

2.000

0.368–10.879

0.415

  1. Note: GIR, glucose infusion rate (mg/kg/min); RDS, respiratory distress syndrome; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; OR, odds ratio; CI, confidence interval; Group I, the GIR usage of 5- < 7 g/kg/day; Group II, the GIR usage of 7–13 g/kg/day; Group III, the GIR usage of > 13–15 g/kg/day
  2. *Significant p-value < 0.05